Startup Lightning Talks - 2022 MIT Health Science Technologies Conference: Innovations in Drug Discovery and Manufacturing
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Vincent Ling, Senior Director, Materials and Innovation, Takeda
Looking for 6-8 startups to present their technology/products during the Startup Lightning Talks and participate in the Lunch Exhibit.
Evonik would like to explore potential collaborations with startups working on new approaches and technologies that can help address innovation challenges in the specialty chemical industry. The selected startups will be invited to present to their executive team in-person on Thursday, June 29.
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio